Genomic Health, Inc
|
(Name of Issuer)
|
Common Stock, par value $0.0001 per share
|
(Title of Class of Securities)
|
37244C101
|
||
(CUSIP Number)
|
Leo Kirby
667 Madison Avenue, 21st Floor
New York, NY 10065
(212) 339-5633
|
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
|
December 2, 2011
|
||
(Date of Event which Requires Filing of this Statement)
|
CUSIP No. 37244C101
|
Page 2 of 8 Pages
|
1
|
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Julian C. Baker
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a) ¨
(b) ¨
|
3
|
SEC USE ONLY
|
|
4
|
SOURCE OF FUNDS (See Instructions)
WC
|
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
41,250
|
8
|
SHARED VOTING POWER
8,955,241
|
|
9
|
SOLE DISPOSITIVE POWER
41,250
|
|
10
|
SHARED DISPOSITIVE POWER
8,955,241
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,996,491
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
30.4%
|
|
14
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
CUSIP No. 37244C101
|
Page 3of 8 Pages
|
1
|
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Felix J. Baker
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a) ¨
(b) ¨
|
3
|
SEC USE ONLY
|
|
4
|
SOURCE OF FUNDS (See Instructions)
WC
|
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
8
|
SHARED VOTING POWER
8,955,241
|
|
9
|
SOLE DISPOSITIVE POWER
0
|
|
10
|
SHARED DISPOSITIVE POWER
8,955,241
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,955,241
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
30.3%
|
|
14
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
Item 5.
|
Interest in Securities of the Issuer.
|
Name
|
Number of
Shares
|
Percent of Class
Outstanding
|
||||||
Baker Bros. Investments, L.P.
|
173,897 | 0.6 | % | |||||
Baker Bros. Investments II, L.P.
|
13,238 | 0.0 | % | |||||
667, L.P.
|
1,306,281 | 4.4 | % | |||||
Baker Brothers Life Sciences, L.P.
|
6,901,703 | 23.3 | % | |||||
14159, L.P.
|
192,064 | 0.7 | % | |||||
FBB Associates
|
173,897 | 0.6 | % | |||||
Baker/Tisch Investments, L.P.
|
194,161 | 0.7 | % | |||||
Julian C. Baker
|
41,250 | 0.1 | % | |||||
Total
|
8,996,491 | 30.4 | % |
Name
|
Date
|
Number of
Shares
|
Transaction
|
Price/ Share
|
||||||
667, L.P.
|
11/21/2011
|
1,630 |
Purchase
|
25.9050 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/21/2011
|
79,984 |
Purchase
|
25.9050 | ||||||
14159, L.P.
|
11/21/2011
|
3,167 |
Purchase
|
25.9050 | ||||||
667, L.P.
|
11/22/2011
|
1,628 |
Purchase
|
26.0302 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/22/2011
|
46,328 |
Purchase
|
26.0302 | ||||||
14159, L.P.
|
11/22/2011
|
2,044 |
Purchase
|
26.0302 | ||||||
667, L.P.
|
11/23/2011
|
655 |
Purchase
|
25.7111 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/23/2011
|
19,429 |
Purchase
|
25.7111 | ||||||
14159, L.P.
|
11/23/2011
|
155 |
Purchase
|
25.7111 | ||||||
667, L.P.
|
11/23/2011
|
1,618 |
Purchase
|
25.8798 | ||||||
Baker Brothers Life Sciences, L.P.
|
11/23/2011
|
47,998 |
Purchase
|
25.8798 | ||||||
14159, L.P.
|
11/23/2011
|
384 |
Purchase
|
25.8798 | ||||||
667, L.P.
|
12/1/2011
|
26,537 |
Purchase
|
27.3300 | ||||||
667, L.P.
|
12/2/2011
|
3,940 |
Purchase
|
28.0349 | ||||||
Baker Brothers Life Sciences, L.P.
|
12/2/2011
|
23,865 |
Purchase
|
28.0349 | ||||||
14159, L.P.
|
12/2/2011
|
639 |
Purchase
|
28.0349 | ||||||
667, L.P.
|
12/2/2011
|
12,123 |
Purchase
|
28.0564 | ||||||
Baker Brothers Life Sciences, L.P.
|
12/2/2011
|
73,430 |
Purchase
|
28.0564 | ||||||
14159, L.P.
|
12/2/2011
|
1,965 |
Purchase
|
28.0564 | ||||||
667, L.P.
|
12/5/2011
|
1,992 |
Purchase
|
28.4999 | ||||||
Baker Brothers Life Sciences, L.P.
|
12/5/2011
|
12,066 |
Purchase
|
28.4999 | ||||||
14159, L.P.
|
12/5/2011
|
323 |
Purchase
|
28.4999 | ||||||
667, L.P.
|
12/5/2011
|
1,385 |
Purchase
|
28.3900 | ||||||
Baker Brothers Life Sciences, L.P.
|
12/5/2011
|
8,390 |
Purchase
|
28.3900 | ||||||
14159, L.P.
|
12/5/2011
|
225 |
Purchase
|
28.3900 |
Item 6.
|
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
|
Item 7.
|
Material to Be Filed as Exhibits.
|
Exhibit 1.
|
Agreement regarding the joint filing of this statement.
|
By:
|
/s/ Julian C. Baker
|
Julian C. Baker
|
|
By:
|
/s/ Felix J. Baker
|
Felix J. Baker
|
By:
|
/s/ Julian C. Baker
|
Julian C. Baker
|
|
By:
|
/s/ Felix J. Baker
|
Felix J. Baker
|